Carl Zeiss Meditec’s Taylor takes helm at VC-backed eye firm
This article was originally published in Clinica
Jim Taylor has joined Oraya Therapeutics, a clinical-stage company developing a radiosurgical system for treating eye disorders, as president and CEO. Mr Taylor has over 25 years’ experience in the medtech industry, of which a significant part was in the ophthalmic sector. Before joining Newark, California-based Oraya, he led ophthalmic diagnostic and treatment systems manufacturer Carl Zeiss Meditec for seven years. Prior to that, he was president of Coherent Medical Group's ophthalmic and surgical lasers business. The appointment of Mr Taylor follows shortly after Oraya raised $42m in series C financing to expand international trials of its treatment for wet age-related macular degeneration.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.